| Outcomes of marginal donors for lung transplantation after ex vivo lung perfusion: a systematic review and meta-analysis D Tian, Y Wang, H Shiiya, CB Sun, Y Uemura, M Sato, J Nakajima The Journal of Thoracic and Cardiovascular Surgery 159 (2), 720-730. e6, 2020 | 53 | 2020 |
| Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided … K Nagaoka, M Shirai, K Taniguchi, A Hosoi, C Sun, Y Kobayashi, ... Journal for immunotherapy of cancer 8 (2), 2020 | 50 | 2020 |
| Respiratory strength and pectoralis muscle mass as measures of sarcopenia: Relation to outcomes in resected non–small cell lung cancer C Sun, M Anraku, T Kawahara, T Karasaki, K Kitano, K Nagayama, ... The journal of thoracic and cardiovascular surgery 163 (3), 779-787. e2, 2022 | 22 | 2022 |
| Low truncal muscle area on chest computed tomography: a poor prognostic factor for the cure of early-stage non-small-cell lung cancer C Sun, M Anraku, T Karasaki, H Kuwano, K Nagayama, JI Nitadori, ... European Journal of Cardio-Thoracic Surgery 55 (3), 414-420, 2019 | 20 | 2019 |
| Prognostic significance of low pectoralis muscle mass on preoperative chest computed tomography in localized non-small cell lung cancer after curative-intent surgery C Sun, M Anraku, T Kawahara, T Karasaki, K Kitano, K Nagayama, ... Lung Cancer 147, 71-76, 2020 | 12 | 2020 |
| Combination of skeletal muscle mass and density predicts postoperative complications and survival of patients with non-small cell lung cancer C Sun, M Anraku, T Kawahara, T Karasaki, C Konoeda, K Kitano, M Sato, ... Annals of Surgical Oncology, 1-9, 2022 | 11 | 2022 |
| Neoantigen dendritic cell vaccination combined with anti-CD38 and CpG elicits anti-tumor immunity against the immune checkpoint therapy-resistant murine lung cancer cell line LLC1 C Sun, K Nagaoka, Y Kobayashi, H Nakagawa, K Kakimi, J Nakajima Cancers 13 (21), 5508, 2021 | 11 | 2021 |
| Tumor location may affect the clinicopathological features and prognosis of thymomas D Tian, H Shiiya, M Sato, CB Sun, M Anraku, J Nakajima Thoracic Cancer 10 (11), 2096-2105, 2019 | 11 | 2019 |
| Immuno-genomic profiling of biopsy specimens predicts neoadjuvant chemotherapy response in esophageal squamous cell carcinoma S Sasagawa, H Kato, K Nagaoka, C Sun, M Imano, T Sato, TA Johnson, ... Cell Reports Medicine 3 (8), 2022 | 9 | 2022 |
| Advances in personalized neoantigen vaccines for cancer immunotherapy C Sun, S Xu BioScience Trends 14 (5), 349-353, 2020 | 8 | 2020 |
| Identification of neoantigens in two murine gastric cancer cell lines leading to the neoantigen-based immunotherapy K Nagaoka, C Sun, Y Kobayashi, T Kanaseki, S Tokita, T Komatsu, ... Cancers 14 (1), 106, 2021 | 6 | 2021 |
| Immunotherapies targeting neoantigens are effective in PD‐1 blockade‐resistant tumors C Sun, K Nagaoka, Y Kobayashi, K Maejima, H Nakagawa, J Nakajima, ... International Journal of Cancer 152 (7), 1463-1475, 2023 | 2 | 2023 |
| ASO Visual Abstract: Combination of Skeletal Muscle Mass and Density Predicts Postoperative Complications and Survival of Patients with Non-small Cell Lung Cancer S Changbo, A Masaki, K Takuya, K Takahiro, K Chihiro, K Kentaro, ... Annals of Surgical Oncology 29 (3), 1827-1828, 2022 | | 2022 |
| ASO Author Reflections: An Evolving Skeletal Muscle Profiling—Towards Precise Host Phenotype and Prognostic Stratification in Non-small Cell Lung Cancer C Sun, M Anraku, J Nakajima Annals of Surgical Oncology, 1-2, 2022 | | 2022 |
| 579 Exploiting tumor neoantigen-targeted immunotherapy in immunologically hot versus cold murine lung cancer models C Sun, K Nagaoka, Y Kobayashi, J Nakajima, K Kakimi Journal for ImmunoTherapy of Cancer 9 (Suppl 2), A608-A608, 2021 | | 2021 |
| 913 A murine gastric cancer YTN16 model for the rational design of combination immunotherapy K Nagaoka, C Sun, Y Kobayashi, K Kakimi Journal for ImmunoTherapy of Cancer 9 (Suppl 2), 2021 | | 2021 |
| Neoantigen vaccine plus CD38 blockade suppress the proliferation of murine cold lung cancer LLC1 C Sun, K Nagaoka, A Hosoi, Y Kobayashi, J Nakajima, K Kakimi Cancer Research 81 (13_Supplement), 1571-1571, 2021 | | 2021 |
| To identify neoantigens relevant to anti-tumor activity is challenging even with NGS-based prediction combined with MHC ligandome profiling K Nagaoka, T Kanaseki, C Sun, A Hosoi, S Tokita, K Maejima, M Fujita, ... Cancer Research 80 (16_Supplement), 6610-6610, 2020 | | 2020 |
| Single-cell RNA-Seq identified an immunosuppressive IL-17 producing tumor-infiltrating T cells in murine gastric tumor model M Shirai, K Nagaoka, K Taniguchi, C Sun, A Hosoi, K Kakimi Cancer Research 80 (16_Supplement), 1550-1550, 2020 | | 2020 |
| Reply to Deng et al. C Sun, M Anraku, J Nakajima European Journal of Cardio-Thoracic Surgery 56 (2), 420-424, 2019 | | 2019 |
